Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent TUBB2A mutation by Ragoussis, Vassilis et al.
1Ragoussis V, et al. J Med Genet 2021;0:1–4. doi:10.1136/jmedgenet-2020-107528
Communication
Using data from the 100,000 Genomes Project to 
resolve conflicting interpretations of a recurrent 
TUBB2A mutation
Vassilis Ragoussis,1,2 Alistair T Pagnamenta   ,1,2 Rebecca L Haines,3 
Edoardo Giacopuzzi,1,2 Martin A McClatchey,4,5 Julian R Sampson,4,5 Mohnish Suri,6 
Alice Gardham,7 Jan- Maarten Cobben,7,8 Deborah Osio,9 Andrew E Fry   ,4,5 
Genomics England Research Consortium, Jenny C Taylor1,2
Neurogenetics
To cite: Ragoussis V, 
Pagnamenta AT, Haines RL, 
et al. J Med Genet Epub 
ahead of print: [please 
include Day Month Year]. 
doi:10.1136/
jmedgenet-2020-107528
 ► Additional material is 
published online only. To view, 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
jmedgenet- 2020- 107528).
For numbered affiliations see 
end of article.
Correspondence to
Dr Alistair T Pagnamenta, 
Wellcome Centre for Human 
Genetics, Oxford University, 
Oxford, Oxfordshire, UK;  
 alistair@ well. ox. ac. uk
Received 17 October 2020
Revised 23 December 2020
Accepted 10 January 2021
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY. 
Published by BMJ.
Defects in tubulin beta 2A class IIa (TUBB2A) are 
associated with a range of complex cerebral cortex 
dysplasias.1 Despite several studies reporting 
NM_001069.3:c.743C>T p.(Ala248Val) as a recur-
rent pathogenic mutation,1 2 it is listed in ClinVar 
with conflicting interpretations. To resolve these 
inconsistencies, we scanned data from the 100,000 
Genomes Project3 (100KGP) and identified 58 
individuals where p.(Ala248Val) had been called. 
Read alignment analysis suggested that the variant 
was genuine in 5/58 individuals, all of whom had 
a primary neurodevelopmental phenotype. In the 
remaining cases which spanned non- specific disease 
phenotypes, low allelic ratios (1%–19%) suggest 
recurrent mismapping artefacts.
Alpha and beta tubulins form heterodimers that 
polymerise to form microtubules, dynamic compo-
nents of the cytoskeleton that play an important role 
in cell division, migration and intracellular transport. 
Variants in several tubulin genes are associated with 
a variety of cortical brain malformation phenotypes, 
including lissencephaly, polymicrogyria, microlis-
sencephaly and simplified gyration, collectively 
termed ‘tubulinopathies’.4 5 A recently described 
tubulinopathy involving TUBB2A (MIM #615763) 
has been associated with brain phenotypes ranging 
from a normal cortex to extensive dysgyria.2 One 
particular TUBB2A variant, p.(Ala248Val), has been 
reported in several studies, in most cases arising de 
novo.1 2 6–8 Additional unpublished clinical cases also 
report a de novo origin ( www. ncbi. nlm. nih. gov/ 
clinvar/ variation/ 127101).
Multiple occurrences of the same de novo 
mutation in patients with overlapping phenotypes 
would typically provide strong evidence supporting 
pathogenicity. However, on closer inspection, 
p.(Ala248Val) becomes harder to interpret, partic-
ularly when applying the American College of 
Medical Genetics and Genomics (ACMG) popula-
tion allele frequency (AF) criteria PM2/BS1.9 The 
AF in gnomAD v2.1.1 is 8/237 044 in exomes and 
79/15 882 in genomes, an unexpected skew for a 
coding variant. In gnomAD v3.1, the global AF of 
400/111 804 rises to 342/24 540 (1.4%) in Afri-
cans, well above the normal threshold for a highly 
penetrant autosomal–dominant condition.
The p.(Ala248Val) variant fails quality control 
filters in the gnomAD genome datasets and is only 
visible when the ‘filtered variants’ checkbox is 
selected. In contrast, it is a PASS variant in the 
exome subset of gnomAD v2.1.1. This inconsis-
tent AF data likely explains the conflicting inter-
pretations in ClinVar—currently one benign, 
one likely benign, two likely pathogenic and two 
pathogenic assessments. This degree of conflict is 
unusual, as diagnostic laboratories apply ACMG 
guidelines conservatively and typically report 
variants as being of uncertain significance when 
doubt arises.
Segmental duplications are known to result in 
reads with low mapping quality on short- read 
sequencing, and this can cause mismapping arte-
facts. Indeed, several regions share similarity 
with TUBB2A. Although the highest identity is 
with TUBB2B, other beta tubulin genes (TUBB3/
TUBB4A/TUBB6) and a pseudogene (TUBB2BP1) 
share >90% identity with TUBB2A exon 4 (online 
supplemental table S1). Notably, TUBB2BP1 
contains the analogous base to p.(Ala248Val) in 
TUBB2A, and this ‘cismorphism’ is in a region rela-
tively depleted for other cismorphisms (figure 1). 
Thus, we speculate that mismapping of reads from 
TUBB2BP1 may result in p.(Ala248Val) being called 
in TUBB2A as an artefact and thus the apparently 
high AF in gnomAD.
Searching data from 78 195 individuals sequenced 
as part of the 100KGP (online supplemental mate-
rial, Methods section) uncovered 58 subjects appar-
ently heterozygous for p.(Ala248Val). On reviewing 
read alignment statistics, two distinct clusters 
were seen. In 5/58 individuals, the p.(Ala248Val) 
variant appeared with allelic ratios of 31%–41%, 
supported by multiple reads across both strands. 
In contrast, for the remaining 53 individuals, the 
variant was observed at lower allelic fractions 
(1%–19%), almost exclusively on positive strand 
reads (figure 2A). The strand bias is similar to that 
seen in gnomAD v2.1.1 and could be explained if 
the variant was a mismapping artefact due to reads 
from TUBB2BP1, as the region of similarity extends 
distally by only 133 bp (figure 1). This mismap-
ping hypothesis is also supported by three nearby 
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TUBB2A- TUBB2BP1 cismorphisms, which can be observed in the 
same reads (figure 2B).
All five patients with apparently ‘genuine’ variants had neuro-
developmental presentations involving intellectual disability. 
Three patients were reported to have seizures (one with electro-
encephalogram showing hypsarrhythymia); three had hypoplasia 
of the corpus callosum; and three had asymmetric ventricules; 
the findings were not atypical of the clinical tubulinopathy spec-
trum (online supplemental table S2 and figure S1). In four of 
five of these cases, genome sequencing had been performed as 
parent–child trios, and in these, the variant was confirmed to 
have arisen de novo. The other 53 individuals spanned several 
disease areas and included unaffected family members, as well 
as germline samples from patients with cancer (online supple-
mental table S3).
Of the five patients where the variant was suspected to be 
genuine, three were white; one was Pakistani; and for one, 
ethnicity data were unavailable. Of the remaining 53 individ-
uals, 34% were African/Caribbean; 30% were Asian; 13% were 
white; and for 23%, ethnicity data were not available. The 
increased prevalence of likely artefactual variant calls in individ-
uals of African ethnicity mirrors the pattern seen in gnomAD. 
This may reflect TUBB2BP1 polymorphisms or additional tracts 
of common paralogous sequence in that population.
On a technical note, where Sanger sequencing is used for vali-
dation, primer design is critically important. In the original study 
by Cushion et al,1 a low allelic fraction was observed in the elec-
tropherogram. Rather than reflecting mosaicism, this was likely 
due to coamplification of TUBB2B (figure 1). We propose an 
alternative reverse primer (online supplemental table S4) that 
increases specificity towards TUBB2A and also demonstrate that 
poor primer design can lead to erroneous validation of NGS arte-
facts (online supplemental figure S2). Where similar methods are 
used, we recommend filtering p.(Ala248Val) variant calls at an 
allelic fraction of >20% and requiring >2 reads on both strands.
For one case, retrospective analysis of exome sequencing 
validated p.(Ala248Val) but further emphasised the impact of 
read lengths on mapping quality (online supplemental figure 
S3). Applying a similar analytical strategy on TUBB2B identi-
fied two patients from 100KGP with cortical brain malfor-
mations harbouring the corresponding p.(Ala248Val) variant 
(online supplemental material), with a similar clustering pattern 
observed (online supplemental figures S4, S5).
Our cautionary tale highlights the difficulty in distinguishing 
bona fide gene- conversion events from mapping artefacts using 
short- read data. It is anticipated that increased uptake of long- 
read sequencing technologies will be beneficial to help fully 
resolve repetitive loci such as this.10 The value of plotting 
Figure 1 Relative positions of segmental duplications and hypothesis for strand bias associated with NC_000006.12:g.3154458G>A, p.(Ala248Val). 
Customised UCSC genome browser session highlighting the positions of segmental duplications showing at least 90% identity (interactive version at: 
https://genome.ucsc.edu/s/AlistairP/TUBB2A_v5). Region shown corresponds to a 900 bp section of exon 4. The RefSeq annotation corresponding to the 
canonical TUBB2A isoform is highlighted. The positions of primers used in the Cushion et al study are indicated by the in silico PCR track—the lack of 
cismorphisms at these sites suggests that TUBB2A and TUBB2B would both be amplified with an equal efficiency. The position of a modified reverse primer 
which contains mismatches with TUBB2B at the 3′ end is indicated. The position of the base in TUBB2BP1 that is analogous to p.(Ala248Val) is labelled. 
Cismorphisms at sites which are also polymorphic in TUBB2A or TUBB2BP1 are also labelled. Other de novo variants detected in 100KGP are indicated, 
although p.(Val49Met) and p.(Arg391His) are not shown as they lie outside the region shown. The schematic diagram below the UCSC session indicates 
relative positions of hypothetically mismapped read pairs from TUBB2BP1 (which lies 23 kb proximal to TUBB2A), which could explain the strand- bias 
observed. Negative strand reads from TUBB2BP1 that harbour the base analogous to p.(Ala248Val) are unlikely to mismap to TUBB2A as the corresponding 
+ve strand paired read then would lie outside the region of similarity. 100KGP, 100,000 Genomes Project; TUBB2A, beta- tubulin isotype 2A.
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read- alignment statistics across a large cohort of individuals 
analysed using a uniform pipeline (eg, 100KGP) is also high-
lighted. It is likely that similar approaches may be useful for 
other genes where conversion events represent an important 
mutational mechanism.
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Figure 2 (A) Allelic ratios for p.(Ala248Val) plotted against the number of negative strand reads supporting the variant in 58 individuals from the 100KGP. 
Five patients have an allelic fraction of >30%, and the variant is also supported by six or more of negative reads. These variants were considered to be real 
and form a discreet cluster compared with the 53 cases with low allelic fractions which are supported almost exclusively by +ve strand reads. Patients 1–5 
are labelled P1–P5. (B) Read alignments shown in the Integrative Genomics Viewer for one case with likely artefact (upper) alongside the likely genuine 
variant in patient 5 (lower). The samples shown correspond to the red data points shown in panel A. Reads are sorted by base and shown using the squished 
option. Three other cismorphisms in the same reads are highlighted—the similarly low allelic fractions are consistent with a mismapping artefact. In the 
lower panel, as well as higher allelic fraction, multiple reads supporting the variant are seen on both strands. 100KGP, 100,000 Genomes Project; TUBB2A, 
beta- tubulin isotype 2A.
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